The Chemours Company
CC
$20.22
-$0.64-3.07%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.95% | -2.13% | -0.86% | 3.93% | 0.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.95% | -2.13% | -0.86% | 3.93% | 0.44% |
| Cost of Revenue | 3.27% | 7.04% | 3.11% | 7.30% | 5.01% |
| Gross Profit | -10.17% | -40.00% | -17.83% | -9.74% | -16.90% |
| SG&A Expenses | 19.83% | -45.88% | -22.22% | 17.11% | -11.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.69% | -0.84% | 0.36% | 8.36% | 3.06% |
| Operating Income | -53.41% | -40.00% | -14.75% | -44.62% | -26.67% |
| Income Before Tax | -- | -- | 259.38% | -478.26% | -100.00% |
| Income Tax Expenses | 40.00% | -141.67% | -- | 1,222.22% | -68.75% |
| Earnings from Continuing Operations | -480.00% | -416.67% | 287.50% | -733.33% | -109.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -480.00% | -408.33% | 287.50% | -735.00% | -109.26% |
| EBIT | -53.41% | -40.00% | -14.75% | -44.62% | -26.67% |
| EBITDA | -31.82% | 10.08% | -6.15% | -25.49% | -7.85% |
| EPS Basic | -533.33% | -406.12% | 286.67% | -731.47% | -108.28% |
| Normalized Basic EPS | -100.00% | -123.29% | -27.84% | -82.87% | -59.69% |
| EPS Diluted | -533.33% | -412.48% | 281.41% | -751.28% | -108.33% |
| Normalized Diluted EPS | -100.00% | -123.29% | -28.05% | -82.79% | -59.42% |
| Average Basic Shares Outstanding | -8.42% | 0.43% | 0.42% | 0.55% | 11.83% |
| Average Diluted Shares Outstanding | -8.42% | 0.43% | 0.72% | 0.08% | 11.07% |
| Dividend Per Share | -- | -65.00% | -65.00% | -65.00% | 0.00% |
| Payout Ratio | 0.94% | 0.92% | 1.18% | -1.06% | -11.80% |